Trials / Terminated
TerminatedNCT03547297
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 212 (actual)
- Sponsor
- Alnylam Pharmaceuticals · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This study will use specific diagnostic tests on a group of patients who are experiencing symptoms typical of acute hepatic porphyria (AHP) to determine how many have the condition, and to potentially help improve the diagnostic process for patients in the future.
Conditions
- Acute Hepatic Porphyria
- Hepatic Porphyrias
- Acute Intermittent Porphyria (AIP)
- Hereditary Coproporphyria (HCP)
- Variegate Porphyria (VP)
- ALA Dehydratase Deficient Porphyria (ADP)
- Porphyria Acute
Timeline
- Start date
- 2018-05-29
- Primary completion
- 2019-01-15
- Completion
- 2019-01-15
- First posted
- 2018-06-06
- Last updated
- 2019-01-25
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03547297. Inclusion in this directory is not an endorsement.